FR2132788B1 - - Google Patents

Info

Publication number
FR2132788B1
FR2132788B1 FR7212355A FR7212355A FR2132788B1 FR 2132788 B1 FR2132788 B1 FR 2132788B1 FR 7212355 A FR7212355 A FR 7212355A FR 7212355 A FR7212355 A FR 7212355A FR 2132788 B1 FR2132788 B1 FR 2132788B1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR7212355A
Other languages
French (fr)
Other versions
FR2132788A1 (enExample
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ACF Chemiefarma NV
Original Assignee
ACF Chemiefarma NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ACF Chemiefarma NV filed Critical ACF Chemiefarma NV
Publication of FR2132788A1 publication Critical patent/FR2132788A1/fr
Application granted granted Critical
Publication of FR2132788B1 publication Critical patent/FR2132788B1/fr
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C205/00—Compounds containing nitro groups bound to a carbon skeleton
    • C07C205/13—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by hydroxy groups
    • C07C205/26—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by hydroxy groups and being further substituted by halogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • General Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
FR7212355A 1971-04-09 1972-04-07 Expired FR2132788B1 (enExample)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
NL7104839.A NL167151C (nl) 1971-04-09 1971-04-09 Werkwijze ter bereiding van geneesmiddelen met anti-parasitaire werking op basis van halogeen bevatten- de 2,2'-methyleendifenolderivaten, alsmede werkwijze ter bereiding van deze geneeskrachtige verbindingen.

Publications (2)

Publication Number Publication Date
FR2132788A1 FR2132788A1 (enExample) 1972-11-24
FR2132788B1 true FR2132788B1 (enExample) 1976-05-14

Family

ID=19812895

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7212355A Expired FR2132788B1 (enExample) 1971-04-09 1972-04-07

Country Status (19)

Country Link
US (1) US3884906A (enExample)
JP (2) JPS5525177B1 (enExample)
AR (2) AR194587A1 (enExample)
AU (1) AU459272B2 (enExample)
BE (1) BE781674A (enExample)
CH (2) CH586182A5 (enExample)
DE (1) DE2215409C3 (enExample)
DK (1) DK143227C (enExample)
ES (1) ES401501A1 (enExample)
FR (1) FR2132788B1 (enExample)
GB (1) GB1346266A (enExample)
HU (1) HU165790B (enExample)
IE (1) IE36209B1 (enExample)
IL (1) IL39108A (enExample)
NL (1) NL167151C (enExample)
PH (2) PH15268A (enExample)
SE (1) SE389331B (enExample)
SU (1) SU580828A3 (enExample)
ZA (1) ZA722331B (enExample)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU4101678A (en) * 1977-11-08 1980-05-01 Ici Australia Ltd Process for killing parasites
FR2549476B1 (fr) * 1983-07-20 1986-04-25 Rech Ind Benzyl-phenyl-osides, procede de preparation et utilisation en therapeutique
US6403652B1 (en) 2000-06-30 2002-06-11 Colgate-Palmolive Company Method and composition
EA011158B1 (ru) * 2004-03-16 2009-02-27 Бёрингер Ингельхайм Интернациональ Гмбх Замещённые глюкопиранозилом бензольные производные, содержащие эти соединения лекарственные средства, их применение и способ их получения
UA91546C2 (uk) * 2005-05-03 2010-08-10 Бьорінгер Інгельхайм Інтернаціональ Гмбх КРИСТАЛІЧНА ФОРМА 1-ХЛОР-4-(β-D-ГЛЮКОПІРАНОЗ-1-ИЛ)-2-[4-((S)-ТЕТРАГІДРОФУРАН-3-ІЛОКСИ)-БЕНЗИЛ]-БЕНЗОЛУ, СПОСІБ ЇЇ ОДЕРЖАННЯ ТА ЇЇ ЗАСТОСУВАННЯ ПРИ ПРИГОТУВАННІ ЛІКАРСЬКИХ ЗАСОБІВ
US7772191B2 (en) 2005-05-10 2010-08-10 Boehringer Ingelheim International Gmbh Processes for preparing of glucopyranosyl-substituted benzyl-benzene derivatives and intermediates therein
PE20080697A1 (es) * 2006-05-03 2008-08-05 Boehringer Ingelheim Int Derivados de benzonitrilo sustituidos con glucopiranosilo, composiciones farmaceuticas que contienen compuestos de este tipo, su uso y procedimiento para su fabricacion
PE20090938A1 (es) * 2007-08-16 2009-08-08 Boehringer Ingelheim Int Composicion farmaceutica que comprende un derivado de benceno sustituido con glucopiranosilo
US8648085B2 (en) * 2007-11-30 2014-02-11 Boehringer Ingelheim International Gmbh 1, 5-dihydro-pyrazolo (3, 4-D) pyrimidin-4-one derivatives and their use as PDE9A mudulators for the treatment of CNS disorders
UA105362C2 (en) 2008-04-02 2014-05-12 Бьорингер Ингельхайм Интернациональ Гмбх 1-heterocyclyl-1, 5-dihydro-pyrazolo [3, 4-d] pyrimidin-4-one derivatives and their use as pde9a modulators
CN102143965A (zh) 2008-09-08 2011-08-03 贝林格尔.英格海姆国际有限公司 吡唑并嘧啶酮及其在治疗中枢神经系统疾病中的用途
US20110014284A1 (en) * 2009-02-13 2011-01-20 Boehringer Ingelheim International Gmbh Pharmaceutical composition, pharmaceutical dosage form, process for their preparation, methods for treating and uses thereof
KR20110118668A (ko) 2009-02-13 2011-10-31 베링거 인겔하임 인터내셔날 게엠베하 1형 당뇨병, 2형 당뇨병, 내당능 장애 또는 고혈당증을 치료하기 위한 sglt­2 억제제
MX339194B (es) 2009-02-13 2016-05-16 Boehringer Ingelheim Int Composicion farmaceutica que comprende un inhibidor de sglt2, un inhibidor de dpp-iv y opcionalmente otro agente antidiabetico, y usos de la misma.
UY32531A (es) 2009-03-31 2010-10-29 Boehringer Ingelheim Int Nuevos compuestos para el tratamiento de trastornos del snc
AR077859A1 (es) * 2009-08-12 2011-09-28 Boehringer Ingelheim Int Compuestos para el tratamiento de trastornos del snc
DK2486029T3 (en) 2009-09-30 2015-08-24 Boehringer Ingelheim Int Methods of making of glucopyranosyl-substituted benzyl-benzene derivatives.
ES2596202T3 (es) * 2009-09-30 2017-01-05 Boehringer Ingelheim International Gmbh Método para la preparación de una forma cristalina de 1-cloro-4-(ß-D-glucopiranos-1-il)-2-[4-((S)-tetrahidrofuran-3-iloxi)-bencil]-benceno
US10610489B2 (en) * 2009-10-02 2020-04-07 Boehringer Ingelheim International Gmbh Pharmaceutical composition, pharmaceutical dosage form, process for their preparation, methods for treating and uses thereof
BR112013003097B1 (pt) 2010-08-12 2021-03-16 Boehringer Ingelheim International Gmbh 6-cicloalquil-pirazolopirimidinonas e composição farmacêutica
US8809345B2 (en) 2011-02-15 2014-08-19 Boehringer Ingelheim International Gmbh 6-cycloalkyl-pyrazolopyrimidinones for the treatment of CNS disorders
AR085689A1 (es) 2011-03-07 2013-10-23 Boehringer Ingelheim Int Composiciones farmaceuticas de metformina, linagliptina y un inhibidor de sglt-2
US9555001B2 (en) 2012-03-07 2017-01-31 Boehringer Ingelheim International Gmbh Pharmaceutical composition and uses thereof
US9192617B2 (en) 2012-03-20 2015-11-24 Boehringer Ingelheim International Gmbh Pharmaceutical composition, methods for treating and uses thereof
CA2812519A1 (en) 2013-04-05 2014-10-05 Boehringer Ingelheim International Gmbh Pharmaceutical composition, methods for treating and uses thereof
US11813275B2 (en) 2013-04-05 2023-11-14 Boehringer Ingelheim International Gmbh Pharmaceutical composition, methods for treating and uses thereof
HRP20190101T1 (hr) 2013-04-05 2019-03-08 Boehringer Ingelheim International Gmbh Terapeutske uporabe empagliflozina
US20140303097A1 (en) 2013-04-05 2014-10-09 Boehringer Ingelheim International Gmbh Pharmaceutical composition, methods for treating and uses thereof
PL2986304T3 (pl) 2013-04-18 2022-05-02 Boehringer Ingelheim International Gmbh Kompozycja farmaceutyczna, sposoby leczenia i jej zastosowania
WO2018087132A1 (en) 2016-11-10 2018-05-17 Boehringer Ingelheim International Gmbh Pharmaceutical composition, methods for treating and uses thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2544826A (en) * 1945-05-08 1951-03-13 Dow Chemical Co Anthelmintic feed composition
US2615052A (en) * 1950-06-23 1952-10-21 Allied Lab Inc 2,2'-methylenebis(4-chloro-6-nitrophenol) and a method for its production
US2739941A (en) * 1952-09-13 1956-03-27 Gen Aniline & Film Corp Germicidal soap composition
NL283922A (enExample) * 1962-10-03

Also Published As

Publication number Publication date
GB1346266A (en) 1974-02-06
NL7104839A (enExample) 1972-10-11
IE36209B1 (en) 1976-09-15
PH15268A (en) 1982-11-02
DE2215409A1 (de) 1973-01-25
AR194587A1 (es) 1973-07-31
US3884906A (en) 1975-05-20
PH14191A (en) 1981-03-26
DK143227C (da) 1981-11-30
DE2215409B2 (de) 1980-02-14
BE781674A (fr) 1972-10-05
JPS5950645B2 (ja) 1984-12-10
JPS557256A (en) 1980-01-19
SE389331B (sv) 1976-11-01
IL39108A (en) 1976-04-30
DK143227B (da) 1981-07-27
AU459272B2 (en) 1975-03-05
HU165790B (enExample) 1974-11-28
DE2215409C3 (de) 1980-10-09
AU4085072A (en) 1973-10-11
NL167151C (nl) 1981-11-16
IE36209L (en) 1972-10-09
ZA722331B (en) 1973-01-31
JPS5525177B1 (enExample) 1980-07-04
ES401501A1 (es) 1975-02-16
CH575372A5 (enExample) 1976-05-14
NL167151B (nl) 1981-06-16
CH586182A5 (enExample) 1977-03-31
IL39108A0 (en) 1972-05-30
FR2132788A1 (enExample) 1972-11-24
AR193590A1 (es) 1973-04-30
SU580828A3 (ru) 1977-11-15

Similar Documents

Publication Publication Date Title
HU165790B (enExample)
CS157136B4 (enExample)
CS154202B2 (enExample)
CS156653B1 (enExample)
CS151303B1 (enExample)
CS151751B1 (enExample)
CS151286B1 (enExample)
CS150717B1 (enExample)
CS150142B1 (enExample)
CS148188B1 (enExample)
CS157279B1 (enExample)
CS153855B1 (enExample)
BG16852A1 (enExample)
CH571829A5 (enExample)
CH561114A5 (enExample)
CH400771A4 (enExample)
CH562285A5 (enExample)
CH603739A5 (enExample)
CH1757071A4 (enExample)
CH1330871A4 (enExample)
BG17082A1 (enExample)
BG17988A1 (enExample)
CH567561A5 (enExample)
BG17132A1 (enExample)
BG16710A1 (enExample)

Legal Events

Date Code Title Description
ST Notification of lapse